Meet us at EPA Congress 2025 in Amsterdam! 🚀 We’re excited to share that Oliver Leatham (VP, RWE) and Ilias Paniaras (Director, RWE) will be attending the EPA Congress in Amsterdam on March 5-6! If you're looking to explore the latest trends in evidence generation and real-world evidence (RWE), discuss your 2025 priorities, or learn more about how our team can support your RWE strategy, we’d love to connect. 📅 Let’s schedule a meeting—drop us a message or comment below! #EPA2025 #RealWorldEvidence #EvidenceGeneration #HealthcareInnovation #RWE
Prescient
Business Consulting and Services
London, UK 23,285 followers
See further, go deeper
About us
We’re a global team of bioscience specialists providing integrated, competitive and customer insights driven strategic consultancy across the full drug lifecycle. We build from a foundation of deep science and clinical-based insights. But while science and strategy may underpin our business, what drives it are deep, collaborative relationships. True partnerships. A true partnership involves going further and digging deeper in search of transformational insights, diverse perspectives and industry-challenging ideas – and applying them with real value. This blend of deep relationships, strategic rigour and scientific expertise unlocks the full potential of healthcare innovation. Innovation with the power to significantly improve people’s lives around the world. Prescient has been a portfolio company of Bridgepoint Development Capital since 2021 and Baird Capital since 2017. For more information, please visit: www.prescienthg.com.
- Website
-
http://www.prescienthg.com
External link for Prescient
- Industry
- Business Consulting and Services
- Company size
- 201-500 employees
- Headquarters
- London, UK
- Type
- Privately Held
- Founded
- 2007
- Specialties
- Product Strategy, Portfolio Strategy, Intelligence, Advisory, Therapeutic Expertise, Commercial Expertise, Clinical Expertise, Competitive Intelligence, Product Differentiation, Oncology, Immunotherapy, Biosimilars, Insights, Portfolio Planning, Clinical Development Strategy, New Product Planning, Value Proposition Development, Launch Strategy, Life Cycle Management, Medical Strategy, Value and Access Strategy, Commercialization Strategy, and Brand Strategy
Locations
Employees at Prescient
Updates
-
What’s next for competitive intelligence (CI) in biopharma? Discover the insights shaping 2025 in our whitepaper, Navigating Tomorrow: Biopharma Competitive Intelligence Trends for 2025. Hear from top CI leaders about the strategies and tools driving success. Get your copy here: https://lnkd.in/eTr4uktj #Biopharma #Biotech #CITrends
-
-
We’re here on Day 2 of the Pharma Market Research Conference! 🎉 Don’t miss our presentation: “Making Sparks Fly: Building Lasting Partnerships for High-Impact Market Research” 📅 When: Starting shortly, from 11:25 AM to 11:55 AM EST! Chris Lewis-DeBoos and Diana Kuritza, PMP are excited to connect with you! If you’re attending, swing by our stand or join us at our session. #PMRC2025 #MarketResearch #PMRC
-
-
At Prescient, we partner with our global biopharma clients to unlock the full potential and value of their innovations—helping to shape strategies that make a real impact on patients' lives. Today, on World Cancer Day, we reaffirm our commitment to supporting the incredible work being done to advance oncology treatments and improve outcomes for those affected by cancer. We stand with the global community in the fight against cancer. Together, we can work towards a cancer-free future. 💙 #WorldCancerDay #Oncology #Biopharma
-
-
We're delighted to welcome Ilias Paniaras to the Prescient team as a Director in our recently established Real World Evidence (RWE) team. With extensive biopharma start-up, business development, marketing and strategy experience, Ilias brings deep expertise in HEOR, evidence generation and medical planning, having held key roles at Neoroute, Decision Resources Group, and Clarivate. At the heart of Ilias' approach is a relentless focus on customer needs and customer delight. In this role, he will be helping clients generate impactful, high-quality evidence to support regulatory, payer, and commercial objectives across global markets. Our Real-World Evidence team offers: ✅ Data-driven market assessments & epidemiology research ✅ RWE study design & execution ✅ Innovative real-world data solutions (e.g., post-marketing studies, outcomes-based agreements)… and much more! We're excited to build a best-in-class RWE capability that empowers our clients with insights that drive decision-making and improved patient outcomes. Welcome to the team, Ilias! #RealWorldEvidence #MarketAccess #RWE
-
-
Five years! Congratulations, Gosha Kucharska 🎉
-
-
Wishing everyone prosperity, success and good fortune as we welcome the Year of the Snake! 🎉🧧 May this year bring wisdom, resilience and new opportunities for all. Happy Lunar New Year! #LunarNewYear #YearOfTheSnake
-
-
We're delighted to welcome Oliver Leatham to the Prescient team as Vice President, leading our Real World Evidence (RWE) team globally! With over 20 years of leadership experience in RWE and Market Access, Oliver has built and led global teams at organisations like PAREXEL, Certara, and Clarivate. His expertise and innovative approach will be pivotal as he spearheads Prescient’s RWE Centre of Excellence, bringing unique data partnerships that unlock insights in therapy areas and markets where such data has historically been unavailable. Under Oliver’s leadership, our growing RWE team will offer enhanced capabilities, including epidemiology forecasting, RWE study design, creative real-world data solutions (e.g., post-marketing studies, outcomes-based agreements), and more. We're thrilled to have Oliver onboard and look forward to the impact he’ll have in driving Prescient’s continued expansion in this fast-evolving space. Welcome to the team, Oliver! #RealWorldEvidence #MarketAccess #RWE
-
-
The US Pharma Market Research Conference (PMRC) is almost here! 📅 When: February 5–6, 2025 📍 Where: Newark, NJ Join Chris Lewis-DeBoos and Diana Kuritza, PMP for their session, “Making Sparks Fly: Building Lasting Partnerships for High-Impact Market Research”, on February 6th, 11:25–11:55 AM EST. Are you attending? Drop by our booth or message Diana Kuritza, PMP and Chris Lewis-DeBoos to set up a meeting in advance—we’d love to connect! Learn more here: https://bit.ly/4giVRkV #PharmaPMR #PharmaInsights #PharmaStrategy #PMRC2025
-